Prosecution Insights
Last updated: April 19, 2026
Application No. 18/481,223

SURGICAL ANCHORS, INSTRUMENTATION, AND METHODS OF USE

Non-Final OA §102§103
Filed
Oct 04, 2023
Examiner
DAVID, SHAUN L
Art Unit
3771
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
International Life Sciences LLC D/B/A Artelon
OA Round
3 (Non-Final)
73%
Grant Probability
Favorable
3-4
OA Rounds
3y 8m
To Grant
92%
With Interview

Examiner Intelligence

Grants 73% — above average
73%
Career Allow Rate
405 granted / 557 resolved
+2.7% vs TC avg
Strong +19% interview lift
Without
With
+19.4%
Interview Lift
resolved cases with interview
Typical timeline
3y 8m
Avg Prosecution
58 currently pending
Career history
615
Total Applications
across all art units

Statute-Specific Performance

§101
2.1%
-37.9% vs TC avg
§103
33.9%
-6.1% vs TC avg
§102
28.2%
-11.8% vs TC avg
§112
26.2%
-13.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 557 resolved cases

Office Action

§102 §103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 02/24/2026 has been entered. Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claim(s) 1-6, 9-14, and 19-21 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by US 2012/0191134 A1 to Martin (hereinafter “Martin”). Regarding claim 1, Martin discloses (see abstract; Figs. 1-11; and [0019]-[0033]) a surgical anchor (2), comprising: an anchor body (22 + 24, Fig. 3, see [0020]), the anchor body extends along a central longitudinal anchor body axis ("CA", see Fig. 7 and [0024]); and an elongated flexible member (10) extending away from the anchor body (see Figs. 6/9); wherein the surgical anchor is configured such that exerting a pull force on the elongated flexible member in a direction substantially aligned with the central longitudinal anchor body axis (indicated by double arrows in Figs. 9-10) imparts a force on the anchor body that includes a rotational force component ("moment", [0026]/[0033]) that is transverse to the central longitudinal anchor body axis, the rotational force component causing the anchor body to rotate (see Figs. 9-11 and [0026]/[0033]). Martin further discloses (claim 2) an elastic member ("mechanism" including movable/deformable parts, [0024]) associated with the anchor body, the elongated flexible member associated with the elastic member (see [0024]); (claim 3) wherein the anchor body comprises a slanted surface (surface in Fig. 6 disposed within recess 36a around which suture 10 loops) that is slanted relative to the central longitudinal anchor body axis (as shown in Fig. 6), wherein exerting the pull force on the elongated flexible member imparts the force on the anchor body including the rotational force component through interaction of the elongated flexible member with the slanted surface (see Figs. 6/9/10 and [0024]/[0026]/[0033]); (claim 4) wherein the slanted surface is asymmetric relative to the central longitudinal anchor body axis (see Fig. 6); (claim 5) wherein the central longitudinal anchor body axis is a longitudinal anchor body axis (see Fig. 7 and [0024]); (claim 6) wherein the slanted surface is a surface of an eyelet extending through the anchor body (see Fig. 6); (claim 9) wherein the slanted surface extends between a distal end and a proximal end (see Fig. 6), wherein the anchor body further comprises at least one proximal bone engagement feature (32A) located on the same side of the anchor body as the distal end of the slanted surface (see Fig. 6 and [0024]); (claim 10) wherein the surgical anchor is configured such that exerting the pull force on the elongated flexible member rotates the proximal bone engagement feature to an engagement position (see Figs. 9-11 and [0026]); (claim 11) wherein the anchor body further comprises a post (22) configured to connect the anchor body to an insertion instrument (8) (see [0020]), wherein the proximal bone engagement feature is located on a proximal end of the post (see Figs. 1/6/7); (claim 12) wherein the proximal end of the post is sloped in an opposite direction to the slanted surface (see Fig. 6); (claim 13) wherein the anchor body further comprises a circumferential engagement feature (distal portion 24's outer circumferential surface) extending around at least a portion of the anchor body (see Fig. 3), wherein the surgical anchor is configured such that exerting the pull force on the elongated flexible member rotates the circumferential engagement feature to an engagement position (see [0026], where distal portion 24 is rotated counter-clockwise to engage the sidewall of the bone hole); (claim 14) wherein the anchor body further comprises a distal engagement feature (24) at a distal end of the anchor body (see Fig. 3), wherein the surgical anchor is configured such that exerting the pull force on the elongated flexible member rotates the distal engagement feature to an engagement position (see [0026]); (claim 19) wherein the anchor body comprises a slanted surface that is slanted relative to the central longitudinal anchor body axis, wherein exerting the pull force on the elongated flexible member imparts the force on the anchor body including the rotational force component through interaction of the elongated flexible member with the slanted surface (see Figs. 6 & 9-11 and [0026]/[0033]); (claim 20) wherein the anchor body further comprises a proximal bone engagement (32A) on a sloped proximal end of the anchor body (see Fig. 6); and (claim 21) wherein the anchor body comprises an eyelet (36A) including slanted surface that is slanted relative to the central longitudinal anchor body axis (surface in Fig. 6 disposed within recess 36a around which suture 10 loops), wherein the anchor body further comprises a proximal bone engagement (32A) on a sloped proximal end of the anchor body; wherein the sloped proximal end is sloped in an opposite direction to the slanted surface (see Fig. 6). Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 7-8 and 15-17 is/are rejected under 35 U.S.C. 103 as being unpatentable over Martin in view of US 2012/0290003 A1 to Dreyfuss (hereinafter “Dreyfuss”) (previously of record). Martin discloses the invention substantially as claimed as discussed above, however, with respect to claims 7-8 and 15-17, Martin fails to specifically disclose wherein the elastic member and the elongated flexible member extend through the eyelet; wherein the elongated flexible member wraps around the slanted surface; wherein the elongated flexible member is fixed to the elastic member in a non-sliding fashion; wherein the elongated flexible member is tied around a central portion of the elastic member; and wherein the elastic member is an elastic mesh. Dreyfuss discloses (see abstract; Figs. 1-3; and [0013]-[0039]), in the same field of endeavor, a surgical anchor (200, Figs. 2-3) comprising an anchor body (10), an elongated flexible member (50) extending away from the anchor body, and an elastic member (60) associated with the anchor body and associated with the elongated flexible member (see Figs. 2-3 and [0013]-[0032]), and further discloses wherein the elastic member and the elongated flexible member extend through the eyelet (see Figs. 2-3); wherein the elongated flexible member wraps around the slanted surface (surface of post 30) wherein the elongated flexible member is fixed to the elastic member in a non-sliding fashion (see Fig. 3 and [0031]; wherein the elongated flexible member is tied around a central portion of the elastic member (see Fig. 3 and [0031]); wherein the elastic member is an elastic mesh (see [0013]/[0034]/[0035]) for the purpose of locking the flexible elongate member (aka, suture) within the suture anchor so that it is not able to freely slide (see [0013]/[0014]/[0022]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified Martin's anchor with the elastic member taught by Dreyfuss in order to lock the flexible elongate member (aka, suture) within the suture anchor so that it is not able to freely slide. Claim(s) 18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Martin in view of Dreyfuss as applied to claim 17 above, and further in view of US 2018/0078255 A1 to Dumanian (hereinafter “Dumanian”) (previously of record) Regarding claim 18, the combination of Martin and Dreyfuss disclose the invention substantially as claimed above, including wherein Dreyfuss discloses that the elastic member (suture 60) can be any flexible strand such as a flexible suture strand or suture tape, among others (see [0013]), but the combination fails to explicitly disclose wherein the elastic mesh is a matrix of knitted fibers with a porosity range of approximately 8um-600um. Dumanian discloses (see abstract; Figs. 1-3; and [0016]-[0030]), in the same field of endeavor, a suture (104) comprising an elastic mesh which is a matrix of knitted fibers (see [0016]) with a porosity range of approximately 8um-600um (see [0028]-[0030]) for the purpose of facilitating and allowing tissue in-growth and integration through the pores when in the body, increasing strength and efficacy of the device while decreasing irritation, inflammation, and local tissue necrosis (see [0030]). It would have been obvious to one having ordinary skill in the art before the effective filing date of the claimed invention to have modified the combination's anchor with the porous mesh matrix as taught by Dumanian in order to facilitate and allow tissue in-growth and integration through the pores when in the body, increasing strength and efficacy of the device while decreasing irritation, inflammation, and local tissue necrosis. Response to Arguments Applicant’s arguments with respect to claim(s) 1-21 have been considered but are moot because the new ground of rejection does not rely on any reference applied in the prior rejection of record for any teaching or matter specifically challenged in the argument. Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to SHAUN L DAVID whose telephone number is (571)270-5263. The examiner can normally be reached M-F 10AM-6:30PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Darwin Erezo can be reached at 571-272-4695. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /SHAUN L DAVID/Primary Examiner, Art Unit 3771
Read full office action

Prosecution Timeline

Oct 04, 2023
Application Filed
Jun 13, 2025
Non-Final Rejection — §102, §103
Sep 17, 2025
Response Filed
Nov 20, 2025
Final Rejection — §102, §103
Jan 20, 2026
Examiner Interview Summary
Jan 20, 2026
Applicant Interview (Telephonic)
Feb 24, 2026
Request for Continued Examination
Mar 14, 2026
Response after Non-Final Action
Mar 27, 2026
Non-Final Rejection — §102, §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12582396
METHODS AND DEVICES FOR MANIPULATING AND FASTENING TISSUE
2y 5m to grant Granted Mar 24, 2026
Patent 12582407
DEVICES AND METHODS FOR APPLYING A HEMOSTATIC CLIP ASSEMBLY
2y 5m to grant Granted Mar 24, 2026
Patent 12569242
DEVICE AND METHOD FOR FIXATING A SUTURE ANCHOR IN HARD TISSUE
2y 5m to grant Granted Mar 10, 2026
Patent 12564402
REVERSE ANASTOMOSIS CLOSURE CLIP
2y 5m to grant Granted Mar 03, 2026
Patent 12564398
IMPLANT DEPLOYMENT DEVICE
2y 5m to grant Granted Mar 03, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

3-4
Expected OA Rounds
73%
Grant Probability
92%
With Interview (+19.4%)
3y 8m
Median Time to Grant
High
PTA Risk
Based on 557 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month